"This report provides novel insights into the patient condition, as well as patterns of unmet needs that correlate to patients' social status, family history, diagnosis pathway, and treatment experience," explained Andrew Schafer, President of ISR. "For drug manufacturers, this report represents an opportunity to better understand the challenges their patients face and enhance development and commercial activities to address the unmet needs of their patients."

ISR presents data regarding statistically significant differences between demographic segments. These segments were defined as: condition, insurance provider, likelihood to enroll in a clinical trial, primary treating physician, length of time since diagnosis, severity of symptoms, age, income, number of treatments, and current treatments.

With ISR's report biopharmaceutical companies and their service providers can:

Quickly get a baseline for "a day in the life" of a severe headache sufferer. Learn about their conditions, quality of life, headache triggers, unmet needs, and treatment satisfaction

Talk in patient-centric language and design marketing and advertising plans to account for the current issues and unmet patient needs

About Industry Standard ResearchIndustry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company's Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.